Año 2022 / Volumen 114 / Número 4
Original
Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study

219-225

DOI: 10.17235/reed.2021.7744/2020

Raquel Ríos León, Eugenia Sánchez Rodríguez, Antonio Martínez Ortega, Enrique Rodríguez de Santiago, Natalia Marcos Carrasco, Javier Graus Morales, Miguel Ángel Rodríguez Gandía, Jose Luis Lledó Navarro, Francisco Gea Rodríguez, Javier María Nuño Vázquez Garza, Agustín Albillos Martínez, Miguel García González,

Resumen
Introduction: despite advances in imaging diagnostic modalities, hepatocellular carcinoma is sometimes incidentally diagnosed on histological examination of the liver explant. The objectives of the study were: a) to compare the characteristics between incidental and known hepatocellular carcinoma; and b) to estimate survival and tumor recurrence after liver transplantation. Material and methods: a retrospective, single-center study was performed. The inclusion criteria were: a) cirrhotic patients, age ≥ 18 years; b) liver transplantation between 1998 and 2018; and c) hepatocellular carcinoma diagnosed via histopathologic examination of the explanted liver. Cholangiocarcinoma and patients with early retransplantation were excluded. Multivariate analysis was performed using binomial logistic regression to assess the factors associated with incidental hepatocellular carcinoma. Kaplan-Meier curves were plotted to explore the impact on overall survival and recurrence free survival. Results: two hundred and sixty-nine patients were enrolled. The prevalence of incidental hepatocellular carcinoma was 4.18 % (95 % CI: 2.89-6.01 %) of all liver transplants performed in cirrhotic patients. The median diameter of the main nodule was smaller in incidental hepatocellular carcinoma (20 vs 27 mm, p = 0.004), although they were more likely to be beyond the Up-to-Seven criteria on explant examination (22.2 % vs 7.5 %, p = 0.001), with no differences in any other histological features. No differences were found in overall survival rates (incidental 70.2 % vs 70.4 %, p = 0.87) or recurrence-free survival (incidental 100 % vs 83.8 %, p = 0.07) at five years. Conclusion: incidental hepatocellular carcinoma are smaller in size and are more frequently found to be beyond the Up-to-Seven criteria. However, no differences were found in overall survival rates or recurrence-free survival, although there was no tumor recurrence in the incidental hepatocellular carcinoma group.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018 Mar 31;391:1301-1314.
2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018;69:182-236.
3. Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocelular carcinoma: an international consensus conference report. Lancet Oncol. 2012 Jan;13:e11-22.
4. Tzartzeva K, Obi J, Rich NE, et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology. 2018 May;154:1706-1718.e1.
5. Singal A, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocelular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009 Jul;30:37-47.
6. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008 Jan;47:97-104.
7. Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010 May;59:638-44.
8. Pérez P, Rodríguez-Perálvarez M, Guerrero L, et al. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact. PLoS One. 2017 Apr 12;12:e0175010.
9. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998 Oct;228:479-90.
10. Sotiropoulos GC, Malagó M, Molmenti EP, et al. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation. 2006 Feb 27;81:531-5.
11. Mourad MM, Algarni A, Aly MA, et al. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant. Exp Clin Transplant. 2015 Aug;13:333-8.
12. Perea Del Pozo E, Bernal Bellido C, Sendín Matín M, et al. Recurrent Hepatocellular Carcinoma After Liver Transplantation: Analysis of Risk Factors. Transplant Proc. 2016 Nov;48:2990-2993.
13. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954 May;7:462-503.
14. Senkerikova R, Frankova S, Sperl J, et al. Incidental hepatocelular carcinoma: risk factors and long-term outcome after liver transplantation. Transplant Proc. 2014 Jun;46:1426-9.
15. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Clin Liver Dis (Hoboken). 2018 Apr 20;11:81.
16. Harris PS, Hansen RM, Gray ME, et al. Hepatocellular carcinoma surveillance: An evidence-based approach. World J Gastroenterol. 2019 Apr 7;25:1550-1559.
17. Castillo E, Pelletier S, Kumer S, et al. Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes. Transplant Proc. 2009 Jan-Feb;41:219-21.
18. Raphe R, Felício HC, Rocha MF, et al. Histopathologic characteristics of incidental hepatocelular carcinoma after liver transplantation. Transplant Proc. 2010 Mar;42:505-6.
19. Piñero F, Mendizabal M, Casciato P, et al. Is recurrence rate of incidental hepatocellular carcinoma after liver transplantation similar to previously known HCC? towards a predictive recurrence score. Ann Hepatol. 2014 Mar-Apr;13:211-8.
20. D'Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl. 2009 Oct;15:1278-87.
21. Schlegel A, Linecker M, Kron P, et al. Risk Assessment in High- and Low-MELD Liver Transplantation. Am J Transplant. 2017 Apr;17:1050-1063.
22. Michard B, Artzner T, Lebas B, et al. Liver transplantation in critically ill patients: Preoperative predictive factors of post-transplant mortality to avoid futility. Clin Transplant. 2017 Dec;31.
Artículos relacionados

Imagen en Patología Digestiva

Síndrome de encefalopatía posterior reversible (PRES) en el postrasplante hepático

DOI: 10.17235/reed.2022.8694/2022

Carta

Neurotoxicidad por ertapenem

DOI: 10.17235/reed.2021.8469/2021

Revisión

La fragilidad física en el contexto del trasplante hepático

DOI: 10.17235/reed.2020.7448/2020

Carta

Manejo de los aneurismas de la arteria hepática

DOI: 10.17235/reed.2020.7219/2020

Imagen en Patología Digestiva

Hemangioendotelioma epitelioide como causa infrecuente de tumor hepático

DOI: 10.17235/reed.2020.7127/2020

Editorial

Cribado del cáncer colorrectal y supervivencia

DOI: 10.17235/reed.2018.5870/2018

Carta al Editor

Post-transplant lymphoproliferative disease after liver transplantation

DOI: 10.17235/reed.2017.5387/2017

Original

Síndrome linfoproliferativo en el trasplante hepático

DOI: 10.17235/reed.2017.4228/2016

Original

Self-expanding metal stents in postoperative esophageal leaks

DOI: 10.17235/reed.2016.3987/2015

Instrucciones para citar
Ríos León R, Sánchez Rodríguez E, Martínez Ortega A, Rodríguez de Santiago E, Marcos Carrasco N, Graus Morales J, et all. Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study. 7744/2020


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 891 veces.
Este artículo ha sido descargado 139 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 18/12/2020

Aceptado: 23/02/2021

Prepublicado: 18/03/2021

Publicado: 07/04/2022

Tiempo de revisión del artículo: 57 días

Tiempo de prepublicación: 90 días

Tiempo de edición del artículo: 475 días


Compartir
Este artículo ha sido valorado por 3 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas